International | Tissuepathology.com

Aiforia expands its presence in Spain through a new clinical account

Erica Goodpaster — Fri, 12 Jun 2026 12:48:19 +0000

Aiforia has been selected via a public tender, won by Palex, to provide AI-assisted diagnostic solutions to a regional health service provider in Spain. Aiforia Technologies Plc, Press Release, June 11, 2026 at 9:30 a.m. EEST Aiforia Technologies has been selected to provide AI-assisted diagnostic solutions to a regional health service provider in Spain. The […]

The post Aiforia expands its presence in Spain through a new clinical account first appeared on Tissuepathology.com.

Photocure and Artera to partner on digital pathology AI test evaluation for Bladder Cancer

Erica Goodpaster — Wed, 10 Jun 2026 12:08:44 +0000

OSLO, Norway, June 8, 2026 /PRNewswire/ — Photocure ASA (OSE: PHO), the Bladder Cancer Company, and Artera, a leading precision medicine company, announce launch of a joint research initiative. The collaboration encompasses Photocure’s blue light cystoscopy (BLC®) registry in bladder cancer and the ArteraAI Bladder Test, an AI-powered digital pathology test currently in development for patients with bladder cancer. […]

The post Photocure and Artera to partner on digital pathology AI test evaluation for Bladder Cancer first appeared on Tissuepathology.com.

DiaDeep and Leica Biosystems Partner to Bring AI Oncology Pathology Applications to the Aperio AI Store

Erica Goodpaster — Thu, 28 May 2026 14:29:19 +0000

DiaDeep and Leica Biosystems: Expanding access to integrated AI tools helps pathologists tackle complex workflows and improve insights Lyon, France and VISTA, CA — May 27, 2026 DiaDeep, a Lyon-based company specialized in medical AI for oncology pathology, and Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions, today […]

The post DiaDeep and Leica Biosystems Partner to Bring AI Oncology Pathology Applications to the Aperio AI Store first appeared on Tissuepathology.com.

Industry Leaders Leica Biosystems, Indica Labs and Lunit Partner to Develop AI-Powered Computational Pathology Assays for PD-L1 and Emerging Biomarkers

Erica Goodpaster — Wed, 27 May 2026 12:04:00 +0000

VISTA, California, ALBUQUERQUE, New Mexico, and SEOUL, South Korea — May 26, 2026 — Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions, and Indica Labs, a global leader in AI-powered digital pathology software, today announced a strategic collaboration with Lunit (KRX:328130.KQ), a leading provider of AI solutions for cancer diagnostics […]

The post Industry Leaders Leica Biosystems, Indica Labs and Lunit Partner to Develop AI-Powered Computational Pathology Assays for PD-L1 and Emerging Biomarkers first appeared on Tissuepathology.com.

AstraZeneca Collaborates with Roche Diagnostics Asia Pacific to Help Accelerate Sustainable Ecosystem for Advanced Pathology in Breast and Lung Cancer

Erica Goodpaster — Tue, 19 May 2026 12:26:00 +0000

SINGAPORE, May 18, 2026 /PRNewswire/ — AstraZeneca and Roche Diagnostics Asia Pacific today announced a three-year Memorandum of Understanding to help advance digital pathology capabilities and elevate cancer care across nine Asia markets, a first in the region. This landmark collaboration aims to accelerate the adoption of AI-powered digital and computational pathology through educational and training initiatives and improve […]

The post AstraZeneca Collaborates with Roche Diagnostics Asia Pacific to Help Accelerate Sustainable Ecosystem for Advanced Pathology in Breast and Lung Cancer first appeared on Tissuepathology.com.

Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics

Erica Goodpaster — Thu, 07 May 2026 13:26:42 +0000

PathAI’s best-in-class Image Management System (IMS) with advanced AI analysis and workflow capabilities will complement Roche’s digital pathology portfolio to drive laboratory efficiency Combining Roche’s strong position in companion diagnostics and PathAI’s advanced AI platform helps accelerate clinical therapy development, foster the discovery of new biomarkers, and create novel diagnostic tools These integrated capabilities will […]

The post Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics first appeared on Tissuepathology.com.